Measurement of Health-Related Quality of Life in Primary Antibody-Deficient Patients

References

• Abolhassani H, Aghamohammadi A, Abolhassani F, et al. (2011). Health policy for common variable immunodeficiency: burden of the disease. J Invest Allergol Clin Immunol, 21(6),454–458. PubMed PMID: 21995178. Epub 2011/10/15. eng.
   PubMed Web of Science ®Google Scholar
• Aghamohammadi A, Abolhassani H, Moazzami K, et al. (2010a). Correlation between common variable immunodeficiency clinical phenotypes and parental consanguinity in children and adults. J Invest Allerg Clin Immunol, 20(5),372–379. PubMed PMID: 20945602.
   PubMed Web of Science ®Google Scholar
• Aghamohammadi A, Allahverdi A, Abolhassani H, et al. (2010b). Comparison of pulmonary diseases in common variable immunodeficiency and X-linked agammaglobulinaemia. Respirology, 15(2),289–2895. PubMed PMID: 20051045.
   PubMed Web of Science ®Google Scholar
• Aghamohammadi A, Mohammadinejad P, Abolhassani H, et al. (2014 May). Primary immunodeficiency disorders in Iran: update and new insights from the third report of the national registry. J Clin Immunol, 34(4),478–490. PubMed PMID: 24659230. Epub 2014/03/25. eng.
   PubMed Web of Science ®Google Scholar
• Aghamohammadi A, Moin M, Kouhi A, et al. (2008). Chromosomal radiosensitivity in patients with common variable immunodeficiency. Immunobiology 213(5),447–454. PubMed PMID: 18472053.
   PubMed Web of Science ®Google Scholar
• Aghamohammadi A, Montazeri A, Abolhassani H, et al. (2011 Mar). Health-related quality of life in primary antibody deficiency. Iran J Allergy Asthma Immunol, 10(1),47–51. PubMed PMID: 21358015. Epub 2011/03/02. eng.
   PubMed Web of Science ®Google Scholar
• Aghamohammadi A, Parvaneh N, Rezaei N. (2009 Nov). Common variable immunodeficiency: a heterogeneous group needs further subclassification. Exp Rev Clin Immunol, 5(6),629–631. PubMed PMID: 20477686.
   PubMed Web of Science ®Google Scholar
• Al-Herz W, Zainal ME, Alenezi HM, et al. (2010 Jun-Sep). Performance status and deaths among children registered in Kuwait National Primary ImmunoDeficiency Disorders Registry. Asian Pacific J Allergy Immunol/launched by the Allergy Immunol Soc Thailand, 28(2–3),141–146. PubMed PMID: 21038783. Epub 2010/11/03. eng.
   PubMed Web of Science ®Google Scholar
• Amiri P, Eslamian G, Mirmiran P, et al. (2012). Validity and reliability of the Iranian version of the Pediatric Quality of Life Inventory 4.0 (PedsQL) Generic Core Scales in children. Health Qual Life Outcomes, 10, 3. PubMed PMID: 22221765. Pubmed Central PMCID: 3311062.
   PubMed Web of Science ®Google Scholar
• Azizi G, Abolhassani H, Asgardoon MH, et al. (2016 Jan). Managing patients with side effects and adverse events to immunoglobulin therapy. Exp Rev Clin Pharmacol, 9(1),91–102. PubMed PMID: 26496172. Epub 2015/10/27. eng.
   PubMed Web of Science ®Google Scholar
• Berger M, Murphy E, Riley P, et al. (2010 Sep). Improved quality of life, immunoglobulin G levels, and infection rates in patients with primary immunodeficiency diseases during self-treatment with subcutaneous immunoglobulin G. South Med J, 103(9),856–863. PubMed PMID: 20689467.
   PubMed Web of Science ®Google Scholar
• Conley ME, Notarangelo LD, Etzioni A. (1999 Dec). Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol (Orlando, Fla), 93(3),190–197. PubMed PMID: 10600329. Epub 1999/12/22. eng.
   PubMed Web of Science ®Google Scholar
• Dashti-Khavidaki S, Aghamohammadi A, Farshadi F, et al. (2009). Adverse reactions of prophylactic intravenous immunoglobulin; a 13-year experience with 3004 infusions in Iranian patients with primary immunodeficiency diseases. J Invest Allergol Clin Immunol, 19(2),139–145. PubMed PMID: 19476018.
   PubMed Web of Science ®Google Scholar
• Helen Chapel ML, Martin Lee, Janne Bjorkander, et al. (2008). Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood, 112(2),277–286.
   Google Scholar
• Kuburovic NB, Pasic S, Susic G, et al. (2014). Health-related quality of life, anxiety, and depressive symptoms in children with primary immunodeficiencies. Patient Preference Adherence, 8, 323–330. PubMed PMID: 24669189. Pubmed Central PMCID: PMC3962310. Epub 2014/03/29. eng.
   Google Scholar
• Mohammadi J, Liu C, Aghamohammadi A, et al. (2009 Nov). Novel mutations in TACI (TNFRSF13B) causing common variable immunodeficiency. J Clin Immunol, 29(6),777–785. PubMed PMID: 19629655.
   PubMed Web of Science ®Google Scholar
• Mohammadinejad P, Mirminachi B, Sadeghi B, et al. (2014 Dec). Distribution of primary immunodeficiency disorders diagnosed in a tertiary referral center,Tehran, Iran (2006-2013). Iran J Immunol: IJI, 11(4),91–282. PubMed PMID: 25549596.
   Web of Science ®Google Scholar
• Mohammadinejad P, Pourhamdi S, Abolhassani H, et al. Primary antibody deficiency in a tertiary referral hospital: A 30-year experiment. J Invest Allergol Clin Immunol, 2015;25(6):416–425. PubMed PMID: 26817138.
   PubMed Web of Science ®Google Scholar
• Montazeri A, Goshtasebi A, Vahdaninia M, Gandek B. (2005 Apr). The Short Form Health Survey (SF-36): translation and validation study of the Iranian version. Qual Life Res: Int J Qual Life Aspects Treat Care Rehabil, 14(3),875–882. PubMed PMID: 16022079. Epub 2005/07/19. eng.
   PubMed Web of Science ®Google Scholar
• Mozaffari H, Pourpak Z, Pourseyed S, et al. (2006 Mar). Health-related quality of life in primary immune deficient patients. Iran J Allergy Asthma Immunol, 5(1),23–27. PubMed PMID: 17242500. Epub 2007/01/24. eng.
   PubMedGoogle Scholar
• Quinti I, Di Pietro C, Martini H, et al. (2012 May). Health related quality of life in common variable immunodeficiency. Yonsei Med J, 53(3),603–610. PubMed PMID: 22477006. Pubmed Central PMCID: PMC3343431. Epub 2012/04/06. eng.
   PubMed Web of Science ®Google Scholar
• Rezaei N, Abolhassani H, Aghamohammadi A, Ochs HD. (2011 May). Indications and safety of intravenous and subcutaneous immunoglobulin therapy. Exp Rev Clin Immunol, 7(3),301–316. PubMed PMID: 21595597.
   PubMed Web of Science ®Google Scholar
• Sadeghi B, Abolhassani H, Naseri A, et al. (2015 May). Economic burden of common variable immunodeficiency: annual cost of disease. Exp Rev Clin Immunol, 11(5),681–688. PubMed PMID: 25804338. Epub 2015/03/26. eng.
   PubMed Web of Science ®Google Scholar
• Tcheurekdjian H, Palermo T, Hostoffer R. (2004 Aug). Quality of life in common variable immunodeficiency requiring intravenous immunoglobulin therapy. Ann Allergy Asthma Immunol: Off Publ Am Coll Allergy Asthma Immunol, 93(2),160–165. PubMed PMID: 15328676. Epub 2004/08/27. eng.
   PubMed Web of Science ®Google Scholar
• Titman P, Allwood Z, Gilmour C, et al. (2014 Oct). Quality of life in children with primary antibody deficiency. J Clin Immunol, 34(7),844–852. PubMed PMID: 25005831. Pubmed Central PMCID: PMC4165866. Epub 2014/07/10. eng.
   PubMed Web of Science ®Google Scholar
• Torabi Sagvand B, Mirminachi B, Abolhassani H, et al. (2014 Sep 5). IgG anti-IgA antibodies in paediatric antibody-deficient patients receiving intravenous immunoglobulin. Allergologia et Immunopathologia, PubMed PMID: 25201762. Epub 2014/09/10. Eng.
   Google Scholar
• Ware JE, Jr., Sherbourne CD. (1992 Jun). The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care, 30(6),473–483. PubMed PMID: 1593914. Epub 1992/06/11. eng.
   PubMed Web of Science ®Google Scholar
• Zebracki K, Palermo TM, Hostoffer R, et al. (2004 December). Health-related quality of life of children with primary immunodeficiency disease: a comparison study. Ann Allergy Asthma Immunol: Off Publ Am Coll Allergy Asthma Immunol, 93(6),557–561. PubMed PMID: 15609765. Epub 2004/12/22. eng.
   PubMed Web of Science ®Google Scholar